tirzepatide weight loss outcomes New Medical Advances. Exploring Products | by James J Busby New drug tirzepatide delivers significant

TOUJEO was studied in 233 pediatric patients (617 years of age) with type 1 diabetes for a mean duration of 26 weeks [see Clinical Studies (14.1)]

doi: 10.1016/j.japr.2025.100519 149

CD8 + T cells were isolated from mouse spleen using EasySep Mouse Naive CD8 + T Cell Isolation Kit (STEMCELL, #19858), and cultured in plate-immobilized anti-CD3 and anti-CD28 in RPMI 1640 medium supplemented with 10% FBS, 100 U/ml penicillin & 100 g/ml streptomycin (Thermo Fisher Scientific, #15070063), 5 ng/ml IL-2 (Biolegend, #575402), 10 mM HEPES (Thermo Fisher Scientific, #15630106), 0.05 mM 2-mercaptoethanol (Thermo Fisher Scientific, #21985023) for 4 days

First, the substantial barriers imposed by these restrictions can hinder patients from acquiring their initially prescribed medications